Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Conventional lung cancer treatments were once limited to surgery, radiation, and chemotherapy. However, gefitinib, a targeted drug, was launched in 2004, and the situation changed. Cancer cases that were highly responsive to gefitinib were later discovered to have epithelial growth factor receptor (...
Spremljeno u:
Daljnji autori: | |
---|---|
Format: | Poglavlje knjige |
Izdano: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Teme: | |
Online pristup: | Get Fullteks DOAB: description of the publication |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Get FullteksDOAB: description of the publication
3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |